These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38742467)

  • 41. Impact of type 2 diabetes on hospitalization and mortality in people with malignancy.
    Kiburg KV; Ward GM; Vogrin S; Steele K; Mulrooney E; Loh M; McLachlan SA; Sundararajan V; MacIsaac RJ
    Diabet Med; 2020 Feb; 37(2):362-368. PubMed ID: 31559651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.
    Oh TK; Song IA
    Acta Diabetol; 2021 Jun; 58(6):771-778. PubMed ID: 33582839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes.
    Katzen J; Kohn R; Houk JL; Ison MG
    Clin Infect Dis; 2019 Jun; 69(1):52-58. PubMed ID: 30304487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
    Shearer AT; Bagust A; Ampudia-Blasco FJ; Martínez-Lage Alvarez B; Pérez Escolano I; París G
    Pharmacoeconomics; 2006; 24 Suppl 1():49-59. PubMed ID: 16800162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure.
    Retwiński A; Kosmalski M; Crespo-Leiro M; Maggioni A; Opolski G; Ponikowski P; Poloński L; Jankowska E; Drzewoski J; Drożdż J
    Kardiol Pol; 2018; 76(9):1336-1343. PubMed ID: 29862487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study.
    Strongman H; D'Oca K; Langerman H; Das R
    Diabetes Obes Metab; 2015 Jun; 17(6):573-580. PubMed ID: 25735201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes.
    Alexopoulos AS; Kahkoska AR; Pate V; Bradley MC; Niznik J; Thorpe C; Stürmer T; Buse J
    JAMA Netw Open; 2021 Nov; 4(11):e2132215. PubMed ID: 34726745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients.
    Tharakan S; Zimmerman B; Ru M; Blanter J; Cascetta K; Tiersten A
    Oncology; 2020; 98(8):589-592. PubMed ID: 32182614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?
    Huang W; Castelino RL; Peterson GM
    Intern Med J; 2014 Mar; 44(3):266-72. PubMed ID: 24405767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.
    Bergmark BA; Bhatt DL; McGuire DK; Cahn A; Mosenzon O; Steg PG; Im K; Kanevsky E; Gurmu Y; Raz I; Braunwald E; Scirica BM;
    Circulation; 2019 Sep; 140(12):1004-1014. PubMed ID: 31362530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health care resource utilization associated with a diabetes center and a general medicine clinic.
    Huang ES; Gleason S; Gaudette R; Cagliero E; Murphy-Sheehy P; Nathan DM; Singer DE; Meigs JB
    J Gen Intern Med; 2004 Jan; 19(1):28-35. PubMed ID: 14748857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
    Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
    Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus.
    Shi Q; Liu S; Fonseca VA; Thethi TK; Shi L
    BMJ Open; 2019 Jul; 9(7):e024954. PubMed ID: 31366635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of metformin on survival in patients with melanoma-national cohort study.
    Urbonas V; Rutenberge J; Patasius A; Dulskas A; Burokiene N; Smailyte G
    Ann Epidemiol; 2020 Dec; 52():23-25. PubMed ID: 32980534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnitude and predictors of hospital admission, readmission, and length of stay among patients with type 2 diabetes at public hospitals of Eastern Ethiopia: a retrospective cohort study.
    Regassa LD; Tola A
    BMC Endocr Disord; 2021 Apr; 21(1):74. PubMed ID: 33866969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.
    Chang YC; Chuang LM; Lin JW; Chen ST; Lai MS; Chang CH
    Diabet Med; 2015 Nov; 32(11):1460-9. PubMed ID: 25970814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?
    Canha MI; Ramos G; Prata R; Lages Martins P; Viúla Ramos M; Coimbra J
    J Gastrointest Cancer; 2024 Mar; 55(1):435-443. PubMed ID: 37987968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database.
    MacDonald MR; Eurich DT; Majumdar SR; Lewsey JD; Bhagra S; Jhund PS; Petrie MC; McMurray JJ; Petrie JR; McAlister FA
    Diabetes Care; 2010 Jun; 33(6):1213-8. PubMed ID: 20299488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.